Results 1-47 of 47 (Search time: 0.014 seconds).
Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link | |
---|---|---|---|---|---|---|---|
1 | 2023 | CLEC5A mediates Zika virus-induced testicular damage | Wang, HW; Li, HH; Wu, SC; Tang, CK; Yu, HY; Chang, YC; Sung, PS; Liu, WL; Su, MP; Yu, GY; Huang, LR; Chen, CH; Hsieh, SL | JOURNAL OF BIOMEDICAL SCIENCE 30, 12 | |||
2 | 2022 | Iron-based Ceramic Composite Nanomaterials for Magnetic Fluid Hyperthermia and Drug Delivery | Chan, MH; Li, CH; Chang, YC; Hsiao, M | PHARMACEUTICS 14(12), 2584 | |||
3 | 2022 | The Aberrant Cancer Metabolic Gene Carbohydrate Sulfotransferase 11 Promotes Non-small Cell Lung Cancer Cell Metastasis via Dysregulation of Ceruloplasmin and Intracellular Iron Balance | Chang, WM; Li, LJ; Chiu, IA; Lai, TC; Chang, YC; Tsai, HF; Yang, CJ; Huang, MS; Su, CY; Lai, TL; Jan, YH; Hsiao, M | TRANSLATIONAL ONCOLOGY 25, 101508 | |||
4 | 2022 | The CHST11 Gene Is Linked to Lung Cancer and Pulmonary Fibrosis | Li, CH; Chan, MH; Chang, YC; Hsiao, M | JOURNAL OF GENE MEDICINE 24(12), e3451 | |||
5 | 2022 | Noncanonical Functions of Fascin-1 and Therapeutic Implications for Fascin-1 Protein in Cancer Progression | Li, CH; Chang, YC; Chan, MH; Liang, SM; Hsiao, M | BIOCHIMICA ET BIOPHYSICA ACTA | |||
6 | 2022 | Ultrasound and Nanomedicine for Cancer-Targeted Drug Delivery: Screening, Cellular Mechanisms and Therapeutic Opportunities | Li, CH; Chang, YC; Hsiao, M ; Chan, MH | PHARMACEUTICS 14(6), 1282 | |||
7 | 2022 | Regorafenib inhibits epithelial-mesenchymal transition and suppresses cholangiocarcinoma metastasis via YAP1-AREG axis | Chang, YC; Li, CH; Chan, MH; Yeh, CN; Chen, MH; Hsiao, M | CELL DEATH & DISEASE 13, 391 | |||
8 | 2022 | FAS receptor regulates NOTCH activity through ERK-JAG1 axis activation and controls oral cancer stemness ability and pulmonary metastasis | Li, LJ; Chang, PM; Li, CH; Lai, TC; Chang, YC; Su, CY; Chen, CL; Chang, WM; Hsiao, M ; Fung, SW | CELL DEATH DISCOVERY 8, 101 | |||
9 | 2022 | Novel Monodisperse FePt Nanocomposites for T2-weighted Magnetic Resonance Imaging: Biomedical Theranostics Applications | Chang, ZX; Li, CH; Chang, YC; Huang, CYF; Chan, MH; Hsiao, M | NANOSCALE ADVANCES 4(2), 377-386 | |||
10 | 2022 | Aldolase A and Phospholipase D1 Synergistically Resist Alkylating Agents and Radiation in Lung Cancer | Chang, YC; Chang, PM; Li, CH; Chan, MH; Lee, YJ; Chen, MH; Hsiao, M | FRONTIERS IN ONCOLOGY 11, 811635 | |||
11 | 2021 | OncomiR miR-182-5p Enhances Radiosensitivity by Inhibiting the Radiation-Induced Antioxidant Effect through SESN2 in Head and Neck Cancer | Lin, MY; Chang, YC; Wang, SY; Yang, MH; Chang, CH; Hsiao, M ; Kitsis, RN; Lee, YJ | ANTIOXIDANTS 10(11), 1808 | |||
12 | 2021 | Magnetically Guided Theranostics: Montmorillonite-based Iron/platinum Nanoparticles for Enhancing In Situ MRI Contrast and Hepatocellular Carcinoma Treatment | Chan, MH; Lu, CN; Chung, YL; Chang, YC; Li, CH; Chen, CL; Wei, DH; Hsiao, M | JOURNAL OF NANOBIOTECHNOLOGY 19, 308 | |||
13 | 2021 | Type V Collagen Alpha 1 Chain Promotes the Malignancy of Glioblastoma through PPRC1-ESM1 Axis Activation and Extracellular Matrix Remodeling | Tsai, HF; Chang, YC; Li, CH; Chan, MH; Chen, CL; Tsai, WC; Hsiao, M | CELL DEATH DISCOVERY 7, 313 | |||
14 | 2021 | Stationed or Relocating: The Seesawing EMT/MET Determinants from Embryonic Development to Cancer Metastasis | Li, CH; Hsu, TI; Chang, YC; Chan, MH; Lu, PJ; Hsiao, M | BIOMEDICINES 9(9), 1265 | |||
15 | 2021 | Galectins in Cancer and the Microenvironment: Functional Roles, Therapeutic Developments, and Perspectives | Li, CH; Chang, YC; Chan, MH; Yang, YF; Liang, SM ; Hsiao, M | BIONMEDICINES 9(9), 1159 | |||
16 | 2021 | Exosomal Components and Modulators in Colorectal Cancer: Novel Diagnosis and Prognosis Biomarkers | Chang, YC; Chan, MH; Li, CH; Fang, CY; Hsiao, M ; Chen, CL | BIOMEDICINES 9(8), 931 | |||
17 | 2021 | Ruxolitinib Combined with Gemcitabine against Cholangiocarcinoma Growth via the JAK2/STAT1/3/ALDH1A3 Pathway | Chung, SY; Hung, YP; Pan, YR; Chang, YC; Wu, CE; Hsu, DS; Chang, PM; Lu, ML; Huang, CY; Su, Y; Hsiao, M ; Yeh, CN; Chen, MH | BIOMEDICINES 9(8), 885 | |||
18 | 2021 | Advanced In Situ MRI and Ultrasonic Theranostics Nanocomposite Platform: Crossing the Blood-Brain Barrier and Improving the Suppression of Glioblastoma Using Iron-Platinum Nanoparticles in Nanobubbles | Chan, MH; Chen, W; Li, CH; Fang, CY; Chang, YC; Wei, DH; Liu, RS; Hsiao, M | ACS APPLIED MATERIALS & INTERFACES 13(23), 26759-26769 | |||
19 | 2021 | Metabolic Protein Phosphoglycerate Kinase 1 Confers Lung Cancer Migration by Directly Binding HIV Tat Specific Factor 1 | Chang, YC; Chan, MH; Li, CH; Yang, CJ; Tseng, YW; Tsai, HF; Chious, J; Hsiao, M | CELL DEATH & DISCOVERY 7, 135 | |||
20 | 2021 | Direct interaction of β‐catenin with nuclear ESM1 supports stemness of metastatic prostate cancer | Pan, KF; Lee, WJ; Chou, CC; Yang, YC; Chang, YC; Chien, MH; Hsiao, M ; Hua, KT | EMBO JOURNAL 40(4), e105450 | |||
21 | 2021 | An annotation-free whole-slide training approach to pathological classification of lung cancer types using deep learning | Chen, CL; Chen, CC; Yu, WH; Chen, SH; Chang, YC; Hsu, TI; Hsiao, M ; Yeh, CY; Chen, CY | NATURE COMMUNICATIONS 12, 1193 | |||
22 | 2020 | The Diverse Roles of TAO Kinases in Health and Diseases | Fang, CY; Lai, TC; Hsiao, M ; Chang, YC | International Journal of Molecular Sciences 21(20), 7463 | |||
23 | 2020 | Omics-based Platforms: Current Status and Potential Use for Cholangiocarcinoma | Chang, YC; Chen, MH; Yeh, CN; Hsiao, M | Biomolecules 10(10), 1377 | |||
24 | 2020 | Squalene synthase promotes the invasion of lung cancer cells via the osteopontin/ERK pathway | Yang, YF; Chang, YC; Jan, YH; Yang, CJ; Huang, MS; Hsiao, M | Oncogenesis 9, 78 | |||
25 | 2020 | IMPAD1 Functions as Mitochondrial Electron Transport Inhibitor that Prevents ROS Production and Promotes Lung Cancer Metastasis Through the AMPK-Notch1-HEY1 Pathway | Yang, YF; Wang, YY; Hsiao, M ; Lo, S; Chang, YC; Jan, YH; Lai, TC; Lee, YC; Hsieh, YC; Yuan, SSF | Cancer Letters 485, 27-37 | |||
26 | 2020 | PRKDC: A New Biomarker and drug target for Checkpoint Blockade Immunotherapy | Tan, KT; Yeh, CN; Chang, YC; Cheng, JH; Fang, WL; Yeh, YC; Hsu, DS; Wu, CE; Liu, CY; Chang, MS; Lu, ML; Chen, SJ; Yee, C; Hsiao, M ; Chen, MH | Journal for ImmunoTherapy of Cancer 8(1), e000485 | |||
27 | 2020 | Overexpression of PSAT1 promotes metastasis of lung adenocarcinoma by suppressing the IRF1-IFNγ axis | Chan, YC; Chang, YC; Chuang, HH; Yang, YC; Lin, YF; Huang, MS; Hsiao, M ; Yang, CJ; Hua, KT | Oncogene 39(12), 2509-2522 | |||
28 | 2020 | Nonenzymatic function of Aldolase A downregulates miR-145 to promote the Oct4/DUSP4/TRAF4 axis and the acquisition of lung cancer stemness | Chang, YC; Yang, YF; Chiou, J; Tsai, HF; Fang, CY; Yang, CJ; Chen, CL; Hsiao, M | Cell Death & Disease 11(3), 195 | |||
29 | 2019 | Follistatin-like protein 1 inhibits lung cancer metastasis by preventing proteolytic activation of osteopontin | Chiou, J; Chang, YC; Tsai, HF; Lin, YF; Huang, MS; Yang, CJ; Hsiao, M | Cancer Research 79(24), 6113-6125 | |||
30 | 2019 | FOXD1 and Gal-3 form a positive regulatory loop to regulate lung cancer aggressiveness | Li, CH; Chang, YC; Hsiao, M ; Liang, SM | Cancers 11(12), 1897 | |||
31 | 2019 | Naa10p Inhibits Beige Adipocyte-Mediated Thermogenesis through N-α-acetylation of Pgc1α | Lee, CC; Shih, YC; Kang, ML; Chang, YC ; Chuang, LM; Devaraj, R; Juan, LJ | Molecular cell 76(3), 500-515.e8 | |||
32 | 2019 | Overexpression of BZW1 is an independent poor prognosis marker and its down-regulation suppresses lung adenocarcinoma metastasis | Chiou, J; Chang, YC; Jan, YH; Tsai, HF; Yang, CJ; Huang, MS; Yu, YL; Hsiao, M | Scientific Reports 9, 14624 | |||
33 | 2019 | Therapeutic targeting of aldolase A interactions inhibits lung cancer metastasis and prolongs survival | Chang, YC; Chiou, J; Yang, YF; Su, CY; Lin, YF; Yang, CN; Lu, PJ; Huang, MS; Yang, CJ; Hsiao, M | Cancer Research 79(18), 4754-4766 | |||
34 | 2019 | Comparison of cofilin-1 and Twist-1 protein expression in human non-small cell lung cancer tissues. | Chang, CY; Chang, SL; Leu, JD; Chang, YC; Hsiao, M ; Lin, LT; Lin, HN; Lee, YJ | Oncology Reports 42, 805-816 | |||
35 | 2019 | Enrichment of aldolase C correlates with low non-mutated IDH1 expression and predicts a favorable prognosis in glioblastomas | Chang, YC; Tsai, HF; Huang, SP; Chen, CL; Hsiao, M ; Tsai, WC | Cancers 11(9), 1238 | |||
36 | 2019 | Ambient particulate matter attenuates Sirtuin1 and augments SREBP1-PIR axis to induce human pulmonary fibroblast inflammation: molecular mechanism of microenvironment associated with COPD. | Tien, CP; Chen, CH; Lin, WY; Liu, CS; Liu, KJ; Hsiao, M ; Chang, YC; Hung, SC | Aging (Albany, NY) 11(13), 4654-4671 | |||
37 | 2019 | ATP Synthase Subunit Epsilon Overexpression Promotes Metastasis by Modulating AMPK Signaling to Induce Epithelial-to-Mesenchymal Transition and Is a Poor Prognostic Marker in Colorectal Cancer Patients | Huang, YJ; Jan, YH; Chang, YC; Tsai, HF; Wu, ATH; Chen, CL; Hsiao, M | Journal of Clinical Medicine 8(7), 1070 | |||
38 | 2019 | AKR1C1 controls cisplatin-resistance in head and neck squamous cell carcinoma through cross-talk with the STAT1/3 signaling pathway | Chang, WM; Chang, YC; Yang, YC; Lin, SK; Chang, MH; Hsiao, M | Journal of Experimental & Clinical Research 38, 245 | |||
39 | 2019 | Ghrelin upregulates oncogenic Aurora A to promote renal cell carcinoma invasion | Lin, TC; Yeh, YM; Fan, WL; Chang, YC; Lin, WM; Yang, TY; Hsiao, M | Cancers 11(3), 303 | |||
40 | 2019 | Over-expression of TNNI3K is associated with early-stage carcinogenesis of cholangiocarcinom | Yeh, CN; Chen, MH; Chang, YC; Wu, RC; Tsao, LC; Wang, SY; Cheng, CT; Chiang, KC; Chen, TW; Hsiao, M ; Weng, WH | Molecular Carcinogenesis 58(2), 270-278 | |||
41 | 2017 | Identification of MALT1 as both a prognostic factor and a potential therapeutic target of regorafenib in cholangiocarcinoma patients | Yeh, CN; Chang, YC; Su, Y; Hsu, DS; Cheng, CT; Wu, RC; Chung, YH; Chiang, KC; Yeh, TS; Lu, ML; Liu, CY; Chang, PM; Chen, MH; Huang, CY; Hsiao, M ; Chen, MH | Oncotarget 8(69), 113444-113459 | |||
42 | 2017 | BICD1 expression, as a potential biomarker for prognosis and predicting response to therapy in patients with glioblastomas | Huang, SP; Chang, YC; Low, QH; Wu, ATH; Chen, CL; Lin, YF; Hsiao, M | Oncotarget 8, 113766-113791 | |||
43 | 2017 | Feedback regulation of ALDOA activates the HIF-1α/MMP9 axis to promote lung cancer progression | Chang, YC; Chan, YC; Chang, MW; Lin, YF; Yang, CJ; Su, CY; Huang, MS; Wu, AT; Hsiao, M | Cancer Letters 403, 28-36 | |||
44 | 2017 | Global Proteomics-based Identification and Validation of Thymosin Beta-4 X-Linked as a Prognostic Marker for Head and Neck Squamous Cell Carcinoma | Chi, LH; Chang, YC; Chang, WM; Chan, YC; Tai, CC; Leung, KW; Chen, CL; Wu, ATH; Lai, TC; Li, YCJ; Hsiao, M | Scientific Reports 7, 9031 | |||
45 | 2017 | A Fas Ligand (FasL)-Fused Humanized Antibody Against Tumor-Associated Glycoprotein 72 Selectively Exhibits the Cytotoxic Effect Against Oral Cancer Cells with a Low FasL/Fas Ratio | Chien, MH; Lee, WJ; Chang, YC; Chang, WM; Lai, TC; Chan, DV; Sharma, R; Lin, YF; Hsiao, M | Molecular Cancer Therapeutics 16(6), 1102-1113 | |||
46 | 2017 | MART-10 represses cholangiocarcinoma cell growth and high vitamin D receptor expression indicates better prognosis for cholangiocarcinoma | Chiang, KC; Yeh, TS; Huang, CC; Chang, YC; Juang, HH; Chang, CT; Pang, JH; Chang, JT; Takano, M; Chen, TC; Kittaka, A; Hsiao, M ; Yeh, CN | Scientific Reports 7, 43773 | |||
47 | 2014 | Squalene synthase induces tumor necrosis factor receptor 1 enrichment in lipid rafts to promote lung cancer metastasis. | Yang, YF; Jan, YH; Liu, YP; Yang, CJ; Su, CY; Chang, YC; Lai, TC; Chiou, J; Tsai, HY; Lu, J ; Shen, CN ; Shew, JY; Lu, PJ; Lin, YF; Huang, MS; Hsiao, M | American journal of respiratory and critical care medicine 190(6), 675-687 |